Recent trend in treatment of obesity

Authors: Deepak Bhosle, Jyoti Bobade, Sukhmeen Kaur, Puja Naik, Dharti Shah, Komal Shivmore
Int J Biol Med Res. 2014; 5(1): 3934-3939  |  PDF File

Abstract

Obesity has become a global problem, affecting countries which are developed and developing. One of the most recent and careful global estimates finds that roughly 500 million adults are obese defined as a Body Mass Index, or BMI of 30 or higher. Obesity is caused due to various factors such as environment, genetics, disease and drugs. Symptoms seen are lethargy, breathlessness, big belly, large body frame. Treatments are doing lifestyle modifications such as implementing dietary and behavioral changes. Obesity can also be controlled by changing the eating habits and doing regular exercise. Pharmacological and surgical interventions are also included in the treatment. Recently many anti-obesity drugs such as fenfluramine, dexfenfluramine,rimonabant, sibutramine, astemizole, terfinadine, phenformin, rofecoxib, valdecoxib and many others. Recently an anti-obesity drug such as belviq, qsymia has been newly introduced in the market.